myirislogo
18 December, 2014 23:46 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 307.05 1.66
Ntpc 132.95 3.83
Hindalco In 153.60 4.31
Tata Stl 401.85 2.13
Sslt 203.75 1.44
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Merck Limited
Merck Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:500126NSE:MERCKBloomberg:EMER@INReuters:MERK.BO
Market Lot: 1Face Value: 10ISIN Demat: INE199A01012
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
13-MAY-14 ICRA has reaffirmed 'AA' to the enhanced Rs 307.5 million fund based and Rs 135 million non-fund based bank limits of Merck. The outlook on the long-term rating is stable. 13-JAN-14 Reliance Mutual Fund A/C Reliance Pharma Fund picked 1.54% stake in Merck for Rs 140.81 million today. It purchased 0.25 million shares at a price of Rs 549 at the NSE. 15-SEP-11 Credit rating agency, ICRA has reaffirmed AA to Rs 267.5 million fund base...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Merck standalone quarterly net falls 38.88%   -IRIS 23-Oct-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Mar-2014(3)31-Dec-2013 (12)31-Dec-2012 (12)
Net sales 1871.527729.626580.70
Other Income50.09214.48201.96
Total Income1921.617944.106782.66
Cost of goods sold1895.987209.125817.87
OPBDIT25.63734.98964.79
PAT35.57558.76784.01
Gross Block---
Equity capital165.99165.99165.99
EPS (Rs.)-33.6647.23
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-15.53 - 20.4711.75 - 15.12
Debt / Equity (x)---
Operating margin (% of OI) 1.3 9.314.2
Net margin (% of OI) 1.9 7.011.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Shiv Sagar Estate A
Dr. Annie Besant Road
Worli
Mumbai
Maharashtra-400 018
PHONE
(022) 6660 9173
FAX
(022) 2495 0307
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer